Multiple sclerosis Trials in Belgrade, Serbia
Conditions / Multiple sclerosis / Belgrade, Serbia
Research into Multiple sclerosis spans multiple therapeutic approaches and trial phases.
22 total trials for this combination
Showing top 10 of 22 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT02634307 | A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1 | COMPLETED | PHASE3 |
| NCT01707992 | The Efficacy, Safety, and Tolerability of Laquinimod in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) | COMPLETED | PHASE3 |
| NCT01892722 | Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT01797965 | Long-Term Extension Study in Participants With Multiple Sclerosis Who Have Completed Study 205MS301 (NCT01064401) to Evaluate the Safety and Efficacy of BIIB019 | TERMINATED | PHASE3 |
| NCT00725985 | Oral Cladribine in Early Multiple Sclerosis (MS) | COMPLETED | PHASE3 |
| NCT02425644 | Oral Ponesimod Versus Teriflunomide In Relapsing MUltiple Sclerosis | COMPLETED | PHASE3 |
| NCT00509145 | Safety and Efficacy of Orally Administered Laquinimod Versus Placebo for Treatment of Relapsing Remitting Multiple Sclerosis (RRMS) | COMPLETED | PHASE3 |
| NCT01006265 | Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of ACT-128800 in Patients With Relapsing-remitting Multiple Sclerosis | COMPLETED | PHASE2 |
| NCT01864148 | Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Participants With Relapsing Forms of Multiple Sclerosis When Used Concurrently With Avonex | COMPLETED | PHASE2 |
| NCT02294058 | Study of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis (MS) | COMPLETED | PHASE3 |